Seres Therapeutics, Inc.【MCRB】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
1Q25 11,821 -45.5%
3Q24 16,460 -41.7%
2Q24 17,875 -61.8%
1Q24 21,702 -50.6%
3Q23 28,253 -34.5%
2Q23 46,792 +6.5%
1Q23 43,969 +10.9%
3Q22 43,116 +8.1%
2Q22 43,935 +22.2%
1Q22 39,649 +35.3%
3Q21 39,882 +67.1%
2Q21 35,954 +78.9%
1Q21 29,303 +34.8%
3Q20 23,861 +30.3%
2Q20 20,099 +12.3%
1Q20 21,743 -5.0%
3Q19 18,317 -22.6%
2Q19 17,905 -25.6%
1Q19 22,887 -2.4%
3Q18 23,675 +6.6%
2Q18 24,053 +4.3%
1Q18 23,460 +16.5%
3Q17 22,210 -8.0%
2Q17 23,060 +4.0%
1Q17 20,143 +30.7%
3Q16 24,143 +145.1%
2Q16 22,174 +152.4%
1Q16 15,416 -
3Q15 9,850 -
2Q15 8,784 -